Hong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend

Bulletin Express

03/18

The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.

The notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1182577465"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182577465\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1182577465?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 16:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182577465","market":"hk","top_or_hot":-1,"title":"Hong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend","media":"Bulletin Express","content":"<p>The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.</p>\n<p>The notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong-listed AIM Vaccine (06660) schedules 30 March 2026 board meeting to approve FY2025 results and consider final dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-18 16:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.</p>\n<p>The notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06660","symbol_name":"艾美疫苗","start_time":0,"source_url":"","article_id":"1182577465","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182577465","pubTimestamp":1773823254,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06660":"艾美疫苗"},"translate_title":"香港上市AIM疫苗(06660)定于2026年3月30日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06660":1},"content_text":"The board of AIM Vaccine Co., Ltd. (Stock Code: 06660) has fixed Monday, 30 March 2026 for its next meeting. According to the company’s announcement filed with Hong Kong Exchanges and Clearing Limited, directors will review and approve the consolidated annual results for the financial year ended 31 December 2025. The agenda also includes discussion of a potential final dividend recommendation and other routine business matters.\nThe notice was issued by Chairman and CEO Mr. Yan Zhou on 18 March 2026. The current board comprises five executive directors—Mr. Yan Zhou, Mr. Xin Zhou, Mr. Shaojun Jia, Mr. Wen Guan and Mr. Jie Zhou—alongside one non-executive director, Mr. Jichen Zhao, and three independent non-executive directors, Professor Ker Wei Pei, Ms. Jie Wen and Mr. Xiaoguang Guo.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}